BALYASNY ASSET MANAGEMENT L.P. - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 247 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q3 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.6%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q3 2022$129,493,000
+4147.1%
1,901,518
+1725.7%
0.40%
+3880.0%
Q4 2021$3,049,000
-88.2%
104,154
-78.7%
0.01%
-94.2%
Q1 2019$25,827,000
+67.5%
487,948
+29.9%
0.17%
+55.0%
Q4 2018$15,418,000
+755.1%
375,593
+742.1%
0.11%
+1287.5%
Q3 2018$1,803,000
-56.4%
44,602
-51.3%
0.01%
-57.9%
Q2 2018$4,140,000
-60.6%
91,574
-57.9%
0.02%
-56.8%
Q1 2018$10,516,000
+3809.3%
217,720
+2409.2%
0.04%
+4300.0%
Q3 2017$269,000
-44.1%
8,677
-71.4%
0.00%
-66.7%
Q1 2016$481,00030,3000.00%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q3 2022
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$680.00%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders